University of Ulster, Newtownabbey, Northern Ireland.
Chron Respir Dis. 2010 Aug;7(3):165-71. doi: 10.1177/1479972310375595.
Respiratory muscle strength is used diagnostically in clinical practice and as an outcome measure in clinical trials in various chronic lung diseases. There is limited data on its repeatability in people with non-CF bronchiectasis. The aim of the present study was to assess the repeatability of maximal inspiratory (P( I)max) and expiratory pressures (P(E)max) in a group of patients with stable, moderate-to-severe non-CF bronchiectasis.
Twenty participants with stable moderate-to-severe non-CF bronchiectasis were recruited. Respiratory muscle strength measurements (three maximal inspiratory and expiratory pressures) were made on 2 separate days. A standard protocol was used, including practice tests, before obtaining three technically acceptable and reproducible readings with a difference of 10% or less between values.
ClinicalTrials.gov: NCT00487149.
The mean (SD) age of the non-CF bronchiectasis group was 63 (9) years. Maximal inspiratory pressures were repeatable with mean (SD) for highest P(I)max, Test 1 and Test 2, 75.90 (20) and 79.40 (19) cmH(2)O, and limits of agreement (mean difference +/- 2SD) -3.50 +/- 20 cmH(2)O, (p = 0.14). Maximal expiratory pressures differed significantly with mean (SD) for highest P(E)max, Test 1 and Test 2, 102.25 (27) and 112.30 (32) cmH(2)O, and limits of agreement (mean difference +/- 2SD) -10.10 +/- 35 cmH(2)O, (p = 0.02). The intraclass correlation coefficient (95% CI) for highest P(I)max and P(E)max was 0.93 (95% CI 0.82 to 0.97) and 0.90 (95% CI 0.76 to 0.96), respectively.
Maximal inspiratory pressure measurements were repeatable during a period of clinical stability in moderate-to-severe non-CF bronchiectasis, suggesting this may be a useful outcome measure in non-CF bronchiectasis. Once a baseline has been established, a second visit is not required. P(E)max was not a repeatable measure and further study is necessary to ascertain how much practice testing is required to obtain an accurate value.
呼吸肌力量在临床实践中用于诊断,并在各种慢性肺部疾病的临床试验中作为结果测量指标。在非 CF 支气管扩张症患者中,其重复性的数据有限。本研究的目的是评估一组稳定的中重度非 CF 支气管扩张症患者的最大吸气(P(I)max)和呼气压力(P(E)max)的重复性。
招募了 20 名稳定的中重度非 CF 支气管扩张症患者。在 2 天内进行了 3 次呼吸肌力量测量(3 次最大吸气和呼气压力)。使用标准方案,包括练习测试,然后获得 3 次技术上可接受且可重复的读数,差值在 10%或以下。
ClinicalTrials.gov:NCT00487149。
非 CF 支气管扩张症组的平均(SD)年龄为 63(9)岁。最高 P(I)max 的吸气压力具有可重复性,测试 1 和测试 2 的最高 P(I)max 分别为 75.90(20)和 79.40(19)cmH(2)O,以及一致性界限(平均差异+/-2SD)为-3.50+/-20 cmH(2)O,(p=0.14)。最大呼气压力差异显著,测试 1 和测试 2 的最高 P(E)max 分别为 102.25(27)和 112.30(32)cmH(2)O,一致性界限(平均差异+/-2SD)为-10.10+/-35 cmH(2)O,(p=0.02)。最高 P(I)max 和 P(E)max 的组内相关系数(95%CI)分别为 0.93(95%CI 0.82 至 0.97)和 0.90(95%CI 0.76 至 0.96)。
在中重度非 CF 支气管扩张症的临床稳定期,最大吸气压力测量具有可重复性,这表明这可能是一种有用的非 CF 支气管扩张症的结果测量指标。一旦建立了基线,就不需要再次就诊。P(E)max 不是一个可重复的测量值,需要进一步研究以确定需要多少练习测试才能获得准确的值。